Impact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocytes During Chronic AntiBody-Mediated Rejection in Kidney Transplantation.

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 27, 2022

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
Kidney Transplantation
Interventions
OTHER

Extracorporeal phototherapy

The principle of ECP is to collect mononucleated cells from the blood by centrifugation. After purification, the mononucleated cells are incubated ex-vivo with a photo-activatable DNA intercalating agent (8-methoxypsoralen, UVADEX®), then re-injected to the patient.

Trial Locations (4)

Unknown

RECRUITING

Chu Besancon, Besançon

RECRUITING

CHU Clermont Ferrand, Clermont-Ferrand

RECRUITING

Chu Saint Etienne, Saint-Etienne

RECRUITING

CHU de STRASBOURG, Strasbourg

All Listed Sponsors
collaborator

Therakos

INDUSTRY

lead

University Hospital, Angers

OTHER_GOV